Medexus Pharmaceuticals Inc
TSX:MDP
Medexus Pharmaceuticals Inc
Revenue
Medexus Pharmaceuticals Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Medexus Pharmaceuticals Inc
TSX:MDP
|
Revenue
$115.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
38%
|
CAGR 10-Years
40%
|
|
Bausch Health Companies Inc
TSX:BHC
|
Revenue
$8.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
Canopy Growth Corp
TSX:WEED
|
Revenue
CA$298.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Cronos Group Inc
TSX:CRON
|
Revenue
$87.2m
|
CAGR 3-Years
23%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Revenue
$2.3B
|
CAGR 3-Years
71%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
T
|
Terrascend Corp
CNSX:TER
|
Revenue
$247.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Medexus Pharmaceuticals Inc's Revenue?
Revenue
115.7m
USD
Based on the financial report for Dec 31, 2023, Medexus Pharmaceuticals Inc's Revenue amounts to 115.7m USD.
What is Medexus Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
40%
Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Medexus Pharmaceuticals Inc have been 2% over the past three years , 38% over the past five years , and 40% over the past ten years .